The semi-annual report on Digital Health’s current state and future outlook, APAC H1 2023 Key Trends, is a must-read. It covers private ventures and includes information on ecosystem development, active partners, venture funding, and current trends. Europe has emerged as a focused and mature ecosystem, securing the top spot globally for ventures with Clinical Evidence while taking second place in venture funding.
Countries included in the analysis: China, India, Hong Kong, Singapore, Japan, South Korea, Australia, Vietnam, Thailand, Indonesia, Pakistan, Taiwan, Malaysia, New Zealand, Myanmar, Sri Lanka, Philippines, Cambodia and Bangladesh
The “Asia Pacific Digital Health Innovation Ecosystem Report on H1 2023 Key Trends” report includes data on the following companies: UNIMED, Medii, Dr. Diary, Provigate, Wise Healthcare, KAKEHASHI, Saluda Medical, Thorough Images, BuyMed, TandemAI, S-Alpha Therapeutics, Holmusk, HealthifyMe, Mindset Health, HealthPlix, Eaglenos, Triple W, Dozee, Neurosensum, Hacarus, Care, Eucalyptus, EOFlow, XtalPi, Smartabase, CNSDose, Pierian, Medtronic, Lilly, Teamworks, Incite Health, Summa Equity, Pfizer, Fosun Pharma, Selgate Healthcare, Hitachi, Gero, WeDoctor, Doc2Us, Cyfuse Biomedical,
Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.
Galen Growth’s proprietary platform, HealthTech Alpha, provides the data source for this report. Corporate Business Development, Business Intelligence, and Digital Health Partnership teams worldwide prefer HealthTech Alpha, the world’s most-trusted Digital Health data, intel, and insights platform. Visit https://www.healthtechalpha.com to learn more about our data or https://www.galengrowth.com research for our reports.
Founded in 2016 by Digital Health experts, Galen Growth empowers global Fortune 500 companies, institutional investors, and promising Digital Health ventures to fast track their digital health strategy to create significant financial and social values. To find out more, visit https://www.galengrowth.com
|ABOUT GALEN GROWTH|
|HEADLINES: 9 pages, 7 charts, 5 tables|
|ECOSYSTEM INSIGHTS: 5 pages, 7 charts, 2 tables|
|INVESTMENT INSIGHTS: 7 pages, 22 charts|
|CLUSTER FOCUS: 4 pages, 2 charts, 1 table|
|THERAPEUTIC FOCUS: 3 pages, 2 charts, 1 table|
|DEEP DIVES: 21 pages, 24 charts, 4 tables|
|NOTEWORTHY: 4 pages, 3 tables|
© Galen Growth 2023